Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ming Xiang

Ming Xiang

Huazhong University of Science and Technology, China

Title: The immune response contribution to pancreatic tumorigenesis in animal models by Reg3g treatment

Biography

Biography: Ming Xiang

Abstract

Regenerating islet-derived protein 3, regulates a variety of important pathologic physiology processes including inflammation, cancer control and cell proliferation. RegIII and IL-6 share the same pathway to accentuate inflammation, and suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of this pathway to bear tumor suppressor function. We studied the immunological mechanisms of Reg3g for promoting the pancreatic cancer. We successfully established subcutaneous transplantation tumor model and pancreatic carcinoma in situ model in C57/BL6j mice. Firstly, we determined critical target cells of Reg3g such as dendritic cells (DC), and CD8+ T cells and CD4+ CD25+ Foxp3+ T cells (Treg); Secondly, we found that Reg3g upregulated key genes in pancreatic tissue such as STAT3, Ki67, Caspase3 gene and downregulated SOCS3 gene, which being collaborative with Th2 type cytokines inhibited tumor immune response, and promoted malignant tumor cell proliferation; Lastly, we confirmed Reg3g inhibited DC migration and phagocytosis, attenuated CD8+ T cells infiltration, decreased negative regulatory factors such as CD152 and PD-1, PD–L1, interfered interaction between CD8+ T cells and DC, inhibited CD8+ T to cells cytotoxicity tumor, and promoted pancreatic cancer formation.